[Association between the influential factors and the effectiveness of pegylated interferon alpha-2a plus ribavirin as a combination treatment for chronic hepatitis C patients].

Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology

Volumn 19, Issue 1, 2011, Pages 34-37

  He, Ling li ^a   Chen, Zhu ^b   Chen, Yang ^b   Xu, Hui ^b   Tang, Hong ^b   Lei, Bing jun ^b   Lei, Xue zhong ^b  

^a SICHUAN UNIVERSITY   (China)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT; MACROGOL DERIVATIVE; PEGINTERFERON ALPHA2A; RECOMBINANT PROTEIN; RIBAVIRIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; DRUG COMBINATION; FEMALE; HEPATITIS C; HUMAN; MALE; MIDDLE AGED; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTIVIRAL AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; MALE; MIDDLE AGED; POLYETHYLENE GLYCOLS; RECOMBINANT PROTEINS; RIBAVIRIN; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84555190606     PISSN: 10073418     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)